Clinical Trials

Showing trials with last updates posted in 2026.

NCT03251989 | COMPLETED
326 participants

Rare CNS Tumors Outcomes &Risk

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-01
Start Date:
2017-08-21
Completion:
2025-05-06
Conditions
  • High Grade Meningioma
  • Ependymoma
  • Medulloblastoma
  • PNET
  • Primary CNS Sarcoma
No Results Yet
NCT03217032 | NOT_YET_RECRUITING | PHASE1
10 participants

Lentiviral FVIII Gene Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2027-06-01
Completion:
2028-05-31
Conditions
  • Hemophilia A
Interventions
  • BIOLOGICAL
No Results Yet
NCT03206099 | RECRUITING
20000 participants

NIAID Centralized Sequencing Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-01
Start Date:
2017-07-31
Completion:
2029-12-31
Conditions
  • Atopy
  • Primary Immunodeficiency
  • Autoimmunity
  • Autoinflammation
No Results Yet
NCT03021460 | COMPLETED | PHASE1
20 participants

Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2017-01-31
Completion:
2025-12-31
Conditions
  • Metastatic Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02997553 | COMPLETED | PHASE3
744 participants

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2017-11-29
Completion:
2022-09-19
Conditions
  • Breast Carcinoma
  • Head and Neck Cancer
  • Melanoma (Skin)
  • Squamous Cell Carcinoma, Skin
  • Cervix Cancer
  • Endometrium Cancer
  • Ovary Cancer
  • Vulva Cancer
  • Anus Cancer
  • Rectum Cancer
Interventions
  • DRUG
  • DEVICE
No Results Yet
NCT02860000 | COMPLETED | PHASE2
96 participants

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2017-07-06
Completion:
2022-01-10
Conditions
  • Estrogen Receptor Status
  • HER2/Neu Negative
  • Invasive Breast Carcinoma
  • Postmenopausal
  • Stage III Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
  • Stage IV Breast Cancer
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page